Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
66.6M
-
Number of holders
-
292
-
Total 13F shares, excl. options
-
58.4M
-
Shares change
-
+3.03M
-
Total reported value, excl. options
-
$5.59B
-
Value change
-
+$258M
-
Put/Call ratio
-
0.53
-
Number of buys
-
141
-
Number of sells
-
-158
-
Price
-
$95.68
Significant Holders of TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) as of Q4 2020
377 filings reported holding TNDM - TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share as of Q4 2020.
TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) has 292 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 58.4M shares
of 66.6M outstanding shares and own 87.81% of the company stock.
Largest 10 shareholders include FMR LLC (6.24M shares), VANGUARD GROUP INC (5.27M shares), BlackRock Inc. (3.48M shares), Jackson Square Partners, LLC (3.19M shares), Capital World Investors (3.07M shares), WELLINGTON MANAGEMENT GROUP LLP (2.26M shares), Invesco Ltd. (1.75M shares), CREDIT SUISSE AG/ (1.41M shares), GILDER GAGNON HOWE & CO LLC (1.39M shares), and PRICE T ROWE ASSOCIATES INC /MD/ (1.37M shares).
This table shows the top 292 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.